DOI:
10.1055/s-00000173
Neuroradiologie Scan
LinksClose Window
References
Sandmann T, Bourgon R, Garcia J et al.
Patients with proneural glioblastoma may derive overall survival benefit from the addition of bevacizumab to first-line radiotherapy and temozolomide: retrospective analysis of the AVAglio trial.
J Clin Oncol 2015;
33: 2735-2744
Access:
We do not assume any responsibility for the contents of the web pages of other providers.